Æterna Zentaris, Inc.(Toronto Stock Exchange : AEZS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.95% | 69.15 | 0.0% | $1917.83m | |
| NVAX | Novavax, Inc. | 9.93% | 146.51 | 96.5% | $1301.01m | |
| SRNE | Sorrento Therapeutics, Inc. | -4.38% | 12.44 | 1.5% | $767.50m | |
| GILD | Gilead Sciences, Inc. | 0.47% | 68.50 | 1.0% | $580.36m | |
| AMGN | Amgen, Inc. | 0.36% | 239.71 | 1.3% | $465.88m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.28% | 612.57 | 2.7% | $378.37m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.05% | 267.29 | 1.9% | $351.81m | |
| BIIB | Biogen, Inc. | 0.32% | 289.45 | 1.4% | $344.47m | |
| ILMN | Illumina, Inc. | -1.69% | 347.56 | 3.5% | $340.75m | |
| BNTX | BioNTech SE | -3.32% | 68.64 | 0.0% | $334.95m | |
| ATNM | Actinium Pharmaceuticals, Inc. | -1.21% | 9.79 | 13.3% | $231.53m | |
| EBS | Emergent BioSolutions, Inc. | -1.09% | 133.47 | 6.4% | $198.26m | |
| VXRT | Vaxart, Inc. | 0.55% | 9.14 | 0.0% | $194.27m | |
| MCRB | Seres Therapeutics, Inc. | -4.62% | 27.26 | 3.6% | $181.12m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.06% | 102.97 | 1.9% | $162.43m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.